Lingman Ma
Impact in
-
- Flavonoids in Medical Research
-
- interferon and immune responses
- Immune Response and Inflammation
Papers in
-
- Cancer therapeutics and mechanisms 2
-
- interferon and immune responses 3
- Atherosclerosis and Cardiovascular Diseases 2
- Immune cells in cancer 2
- Co-authors
- Changlin Zhou (9 shared papers)Yiran Zhou (6 shared papers)Jie Dou (5 shared papers)Baiyong Shen (3 shared papers)Zhaoshi Bai (8 shared papers)Qidi Ying (3 shared papers)Mengqi Su (1 shared paper)Qing Wei (2 shared papers)
- Journals
- Cell Death and Disease (2 papers)International Journal of Biological Macromolecules (1 paper)Naunyn-Schmiedeberg s Archives of Pharmacology (1 paper)Archives of Pharmacal Research (1 paper)Expert Opinion on Therapeutic Targets (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Lingman Ma
24 papers receiving 434 citations
Peers
Comparison fields: 5 of 79
- Pharmacology 87
- Immunology 88
- Cancer Research 62
- Pharmacology 35
- Biochemistry 19
Countries citing papers authored by Lingman Ma
This map shows the geographic impact of Lingman Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingman Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingman Ma more than expected).
Fields of papers citing papers by Lingman Ma
This network shows the impact of papers produced by Lingman Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingman Ma. The network helps show where Lingman Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingman Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 104 | |
| 2 | 2019 | 77 | |
| 3 | 2019 | 44 | |
| 4 | 2020 | 36 | |
| 5 | 2018 | 36 | |
| 6 | 2023 | 21 | |
| 7 | 2019 | 14 | |
| 8 | 2017 | 13 | |
| 9 | 2021 | 13 | |
| 10 | 2022 | 12 | |
| 11 | 2019 | 9 | |
| 12 | 2015 | 8 | |
| 13 | 2021 | 7 | |
| 14 | 2018 | 7 | |
| 15 | 2024 | 6 | |
| 16 | 2014 | 6 | |
| 17 | 2024 | 5 | |
| 18 | 2016 | 5 | |
| 19 | 2024 | 3 | |
| 20 | 2017 | 3 |
About Lingman Ma
Lingman Ma is a scholar working on Molecular Biology, Immunology, Epidemiology, Organic Chemistry and Pharmacology, having authored 24 papers that have together received 435 indexed citations. Recurring topics across this work include interferon and immune responses (3 papers), Nanoplatforms for cancer theranostics (2 papers), Atherosclerosis and Cardiovascular Diseases (2 papers), Diabetes Treatment and Management (2 papers), Adipokines, Inflammation, and Metabolic Diseases (2 papers), Immune cells in cancer (2 papers), Autophagy in Disease and Therapy (2 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Pharmacology (87 citations), Immunology (88 citations), Cancer Research (62 citations), Pharmacology (35 citations) and Biochemistry (19 citations). Lingman Ma has collaborated with scholars based in China and United States. Frequent co-authors include Changlin Zhou, Yiran Zhou, Jie Dou, Baiyong Shen, Zhaoshi Bai, Qidi Ying, Mengqi Su, Qing Wei, Xin Xie and Qian Yu. Their work appears in journals such as Cell Death and Disease, International Journal of Biological Macromolecules, Naunyn-Schmiedeberg s Archives of Pharmacology, Archives of Pharmacal Research and Expert Opinion on Therapeutic Targets.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.